These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10344754)

  • 41. Decreased generation of anti-tumor immunity after intrasplenic immunization.
    Cayeux S; Qin Z; Dörken B; Blankenstein T
    Eur J Immunol; 2001 May; 31(5):1392-9. PubMed ID: 11465096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells.
    Zheng G; Liu S; Wang P; Xu Y; Chen A
    Cancer Res; 2006 Jul; 66(13):6793-9. PubMed ID: 16818656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
    Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
    Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).
    McHugh RS; Ahmed SN; Wang YC; Sell KW; Selvaraj P
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8059-63. PubMed ID: 7544014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery.
    Bumgarner GW; Shashidharamurthy R; Nagarajan S; D'Souza MJ; Selvaraj P
    J Control Release; 2009 Jul; 137(2):90-7. PubMed ID: 19328830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
    Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
    Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
    Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function.
    Brunschwig EB; Levine E; Trefzer U; Tykocinski ML
    J Immunol; 1995 Dec; 155(12):5498-505. PubMed ID: 7499830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes.
    Yang G; Mizuno MT; Hellström KE; Chen L
    J Immunol; 1997 Jan; 158(2):851-8. PubMed ID: 8993003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro.
    Kaufmann AM; Gissmann L; Street D; Schreckenberger C; Hunter M; Qiao L
    Cell Immunol; 1996 May; 169(2):246-51. PubMed ID: 8620552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces anti-tumor immune response].
    Zhang JM; Wu XH; Zhang X; Zhang Y; Luo CL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):564-9. PubMed ID: 22325213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.
    Gilligan MG; Knox P; Weedon S; Barton R; Kerr DJ; Searle P; Young LS
    Gene Ther; 1998 Jul; 5(7):965-74. PubMed ID: 9813668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules.
    Cimino AM; Palaniswami P; Kim AC; Selvaraj P
    Immunol Res; 2004; 29(1-3):231-40. PubMed ID: 15181285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1 via recombinant adenovirus.
    Lee CT; Ciernik IF; Wu S; Tang DC; Chen HL; Truelson JM; Carbone DP
    Cancer Gene Ther; 1996; 3(4):238-44. PubMed ID: 8853548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.